Alternative Data for Medpace
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 698 | Sign up | Sign up | Sign up |
| Sentiment | 95 | Sign up | Sign up | Sign up |
| Webpage traffic | 193,000 | Sign up | Sign up | Sign up |
| Employee Rating | 56 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| App Downloads | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 5 | Sign up | Sign up | Sign up |
| Facebook Followers | 5,440 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 1 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 1,565 | Sign up | Sign up | Sign up |
| X Mentions | 4 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 866 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 38 | Sign up | Sign up | Sign up |
| Linkedin Employees | 6,224 | Sign up | Sign up | Sign up |
About Medpace
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia.
| Price | $602.25 |
| Target Price | Sign up |
| Volume | 140,600 |
| Market Cap | $16.6B |
| Year Range | $293.03 - $620.59 |
| Dividend Yield | 0% |
| PE Ratio | 41.15 |
| Analyst Rating | 33% buy |
| Earnings Date | February 9 '26 |
| Industry | Medical Devices |
In the news
 |
Medpace (MEDP) Stock Drops Despite Market Gains: Important Facts to NoteJanuary 23 - Yahoo |
|
Vulcan Value Partners’ Thoughts on Medpace Holdings (MEDP)January 22 - Yahoo |
|
Is Medpace Holdings (MEDP) Still Attractive After 81% One-Year Surge In Share Price?January 17 - Yahoo |
|
How Investors Are Reacting To Medpace Holdings (MEDP) Strong Organic Growth And Efficient Capital UseJanuary 16 - Yahoo |
|
Medpace (MEDP): Buy, Sell, or Hold Post Q3 Earnings?January 15 - Yahoo |
|
Why the Market Dipped But Medpace (MEDP) Gained TodayJanuary 14 - Yahoo |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '25 | 660M | 463M | 197M | 111M | 150M | 3.860 |
| Q2 '25 | 603M | 423M | 180M | 90M | 118M | 3.103 |
| Q1 '25 | 559M | 380M | 178M | 115M | 120M | 3.670 |
| Q4 '24 | 537M | 358M | 178M | 117M | 133M | 3.681 |
| Q3 '24 | 533M | 364M | 169M | 96M | 120M | 3.010 |
Insider Transactions View All
| Troendle August J. filed to sell 646,184 shares at $590.7. December 4 '25 |
| Troendle August J. filed to sell 646,852 shares at $590.5. December 3 '25 |
| Troendle August J. filed to sell 652,550 shares at $593.3. December 3 '25 |
| Troendle August J. filed to sell 675,728 shares at $593.5. December 1 '25 |
| Troendle August J. filed to sell 690,879 shares at $606.9. December 1 '25 |
Similar companies
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Gilbert Cisneros |
Nov 19, 25 | Sell | $1K - $15K |
| Lisa McClain |
Sep 15, 25 | Sell | $1K - $15K |
| David Taylor |
Sep 3, 25 | Sell | $1K - $15K |
Read more about Medpace (MEDP) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, app downloads, 4chan mentions, facebook engagement, facebook followers, reddit mentions, stocktwits mentions, stocktwits subscribers, x mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
FAQ - Medpace
The Market Cap of Medpace is $16.6B.
As of today, Medpace's PE (Price to Earnings) ratio is 41.15.
Medpace will report its next earnings on February 9 '26.
Currently, the price of one share of Medpace stock is $602.25.
The MEDP stock price chart above provides a comprehensive visual representation of Medpace's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Medpace shares. Our platform offers an up-to-date MEDP stock price chart, along with technical data analysis and alternative data insights.
As of our latest update, Medpace (MEDP) does not offer dividends to its shareholders. Investors interested in Medpace should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
Some of the similar stocks of Medpace are Boston Scientific, Edwards Lifesciences, Intuitive Surgical, Medtronic, and Stryker.
